Does finding a rare mutation accomplish anything?

Update: 2024-04-10

Description

Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.

Comments

In Channel

AI Powered Multiomics: Joachim Schmid on Data Analysis at Illumina

2025-03-0323:34

The Genomic Revolution Transforming Public Health in Africa with Next-Generation Sequencing (NGS) with Professor Martin Nyaga

2025-01-2332:50

Illumina Scales Variant Calling and Genome Interpretation to Improve Gaps in Genetic Testing

2024-04-1831:19

How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina's AI Lab, Kyle Farh

2024-04-1828:20

Two Industry Leaders on the Growing Complexity of Genomic Cancer Data

2024-04-1832:51